An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
A rostral brainstem structure, the pedunculopontine nucleus (PPN), is severely affected by Parkinson's disease (PD) pathology and is regarded a promising target for therapeutic deep-brain stimulation (DBS). However, understanding the PPN's role in PD and assessing the potential of DBS are...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2015
|
| _version_ | 1826289142938468352 |
|---|---|
| author | Pienaar, I Harrison, I Elson, J Bury, A Woll, P Simon, A Dexter, D |
| author_facet | Pienaar, I Harrison, I Elson, J Bury, A Woll, P Simon, A Dexter, D |
| author_sort | Pienaar, I |
| collection | OXFORD |
| description | A rostral brainstem structure, the pedunculopontine nucleus (PPN), is severely affected by Parkinson's disease (PD) pathology and is regarded a promising target for therapeutic deep-brain stimulation (DBS). However, understanding the PPN's role in PD and assessing the potential of DBS are hampered by the lack of a suitable model of PPN degeneration. Rats were rendered Parkinsonian through a unilateral substantia nigra pars compacta (SNpc) stereotaxic injection of the proteasome inhibitor Lactacystin, to investigate whether the lesion's pathological effects spread to impact the integrity of PPN cholinergic neurons which are affected in PD. At 5 weeks post-surgery, stereological analysis revealed that the lesion caused a 48 % loss of dopaminergic SNpc neurons and a 61 % loss of PPN cholinergic neurons, accompanied by substantial somatic hypotrophy in the remaining cholinergic neurons. Magnetic resonance imaging revealed T2 signal hyper-/hypointensity in the PPN of the injected hemisphere, respectively at weeks 3 and 5 post-lesion. Moreover, isolated PPN cholinergic neurons revealed no significant alterations in key autophagy mRNA levels, suggesting that autophagy-related mechanisms fail to protect the PPN against Lactacystin-induced cellular changes. Hence, the current results suggest that the Lactacystin PD model offers a suitable model for investigating the role of the PPN in PD. |
| first_indexed | 2024-03-07T02:24:24Z |
| format | Journal article |
| id | oxford-uuid:a518692a-f846-4e2b-bfc9-649aa462b88e |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:24:24Z |
| publishDate | 2015 |
| record_format | dspace |
| spelling | oxford-uuid:a518692a-f846-4e2b-bfc9-649aa462b88e2022-03-27T02:38:04ZAn animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a518692a-f846-4e2b-bfc9-649aa462b88eEnglishSymplectic Elements at Oxford2015Pienaar, IHarrison, IElson, JBury, AWoll, PSimon, ADexter, DA rostral brainstem structure, the pedunculopontine nucleus (PPN), is severely affected by Parkinson's disease (PD) pathology and is regarded a promising target for therapeutic deep-brain stimulation (DBS). However, understanding the PPN's role in PD and assessing the potential of DBS are hampered by the lack of a suitable model of PPN degeneration. Rats were rendered Parkinsonian through a unilateral substantia nigra pars compacta (SNpc) stereotaxic injection of the proteasome inhibitor Lactacystin, to investigate whether the lesion's pathological effects spread to impact the integrity of PPN cholinergic neurons which are affected in PD. At 5 weeks post-surgery, stereological analysis revealed that the lesion caused a 48 % loss of dopaminergic SNpc neurons and a 61 % loss of PPN cholinergic neurons, accompanied by substantial somatic hypotrophy in the remaining cholinergic neurons. Magnetic resonance imaging revealed T2 signal hyper-/hypointensity in the PPN of the injected hemisphere, respectively at weeks 3 and 5 post-lesion. Moreover, isolated PPN cholinergic neurons revealed no significant alterations in key autophagy mRNA levels, suggesting that autophagy-related mechanisms fail to protect the PPN against Lactacystin-induced cellular changes. Hence, the current results suggest that the Lactacystin PD model offers a suitable model for investigating the role of the PPN in PD. |
| spellingShingle | Pienaar, I Harrison, I Elson, J Bury, A Woll, P Simon, A Dexter, D An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title | An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title_full | An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title_fullStr | An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title_full_unstemmed | An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title_short | An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease. |
| title_sort | animal model mimicking pedunculopontine nucleus cholinergic degeneration in parkinson s disease |
| work_keys_str_mv | AT pienaari ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT harrisoni ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT elsonj ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT burya ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT wollp ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT simona ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT dexterd ananimalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT pienaari animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT harrisoni animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT elsonj animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT burya animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT wollp animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT simona animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease AT dexterd animalmodelmimickingpedunculopontinenucleuscholinergicdegenerationinparkinsonsdisease |